Leveraging Cholesterol-Functionalized Cyclodextrin Nanosponges for Enhanced Drug Delivery in Cancer Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26031213 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ilona Krabicová und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Humanities and Education, Technical University of Liberec, 461 17 Liberec, Czech Republic. Hauptthemen laut MEDLINE: Cholesterol, Cyclodextrins, Resveratrol, Drug Delivery Systems. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Youth and Sports, Czech Republic, Ministry of Education, Youth and Sports of the Czech Republic.
Abstract (Originalsprache)
Cholesterol, the essential building block of cellular membranes, has proven to be a useful tool for increasing the biocompatibility and bioavailability of drug delivery systems in cancer treatment. Resveratrol, a natural polyphenolic compound with promising anticancer properties, faces significant limitations due to its low solubility and bioavailability, hindering its clinical utility. Therefore, in the present study, we aimed to design cholesterol-functionalized cyclodextrin nanosponges (Chol-NSs) with a tunable cholesterol content to optimize resveratrol encapsulation and delivery. Both formulations, free carbonyl diimidazole (CDI) NSs and functionalized Chol-NSs, demonstrated high drug loading and encapsulation efficiency. In vitro experiments revealed that cholesterol incorporation significantly improved the cellular uptake of nanocarriers and potentiated the cytotoxic effects of resveratrol on breast cancer cells. Importantly, both free CDI NSs and functionalized Chol-NSs, even at varying cholesterol percentages, demonstrated a safe profile against both fibroblast and breast cancer cell lines. These results indicate that cholesterol-functionalized nanosponges represent a promising platform for the effective and safe delivery of natural compounds in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, Humanities and Education, Technical University of Liberec, 461 17 Liberec, Czech Republic.
- Department of Chemistry, University of Turin, 10125 Turin, Italy.
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- NIS Interdepartmental Centre, 10125 Turin, Italy.
- Department of Oncology, University of Torino, 10060 Candiolo, Italy.
- Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
ORCID-Profile: Ilona Krabicová, Yousef Khazaei Monfared, Fabrizio Caldera, Christopher Hobbs, Rosangela Santalucia, Adrián Matencio
Förderung
- Ministry of Education, Youth and Sports, Czech Republic
- Ministry of Education, Youth and Sports of the Czech Republic
Zitieren
APA
Krabicová, I., Khazaei Monfared, Y., Caldera, F., Mahmoudian, M., Hobbs, C., Santalucia, R., Appleton, S. L., Matencio, A., Zakeri-Milani, P., & Trotta, F. (2025). Leveraging Cholesterol-Functionalized Cyclodextrin Nanosponges for Enhanced Drug Delivery in Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031213
Vancouver
Krabicová I, Khazaei Monfared Y, Caldera F, Mahmoudian M, Hobbs C, Santalucia R, et al. Leveraging Cholesterol-Functionalized Cyclodextrin Nanosponges for Enhanced Drug Delivery in Cancer Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031213
BibTeX
@article{Krabicov2025,
author = {Krabicová, Ilona and Khazaei Monfared, Yousef and Caldera, Fabrizio and Mahmoudian, Mohammad and Hobbs, Christopher and Santalucia, Rosangela and Appleton, Silvia Lucia and Matencio, Adrián and Zakeri-Milani, Parvin and Trotta, Francesco},
title = {Leveraging Cholesterol-Functionalized Cyclodextrin Nanosponges for Enhanced Drug Delivery in Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26031213}
}
EUVIMED